Keywords: bon usage; DMARDs; inflammation; méthotrexate; molécule biologique; polyarthrite rhumatoïde; biological molecule; DMARDs; good practice; inflammation; methotrexate; rheumatoid arthritis;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: RA; rheumatoid arthritis; CM; Chinese medicine; TNF; tumor necrosis factor; DMARDs; disease, modifying anti-rheumatic drugs; EULAR; European League Against Rheumatism; DAS28; disease activity score in 28 joints; BMI; body mass index; ROC; receiver operato
Keywords: RA; rheumatoid arthritis; RF; rheumatoid factor; ACPA; anti-citrullinated protein antibodies; AA; arachidonic acid; PG; prostaglandins; LT; leukotrienes; TX; thromboxanes; LX; lipoxins; NSAID; non steroidal anti-inflammatory drugs; COXIB; COX-2 selective
Keywords: RA; rheumatoid arthritis; RCT; randomized controlled trial; DMARDs; Non-biologic Disease-Modifying Anti-Rheumatic Drugs; HDL; high-density lipoprotein; LDL; low-density lipoprotein; ESR; erythrocyte sedimentation rate; CRP; C-reactive protein; TG; triglyc
Keywords: Geriatrics; DMARDs; Rheumatology; Rheumatoid arthritis; Tofacitinib; Apremilast;
Keywords: Rheumatoid arthritis; Cardiovascular disease; DMARDs; NSAIDs; Corticosteroids;
Keywords: cfDNA; circulating cell-free DNA; CIC; circulating immune cells; DMARDs; disease-modifying disease drugs; ExV; extracellular vesicles; FLS; fibroblast-like synoviocytes; IFN; interferon; IL; interleukin; NSAIDs; nonsteroidal anti-inflammatory drugs; RA; r
Keywords: Biologics; Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis; AEs; adverse events; CD; Crohn's disease; DMARDs; disease-modifying antirheumatic drug; IBD; inflammatory bowel disease; MTX; methotrexate; RA; rheumatoid arthritis; RTX; rit
Keywords: ACR; American College of Rheumatology; AEs; advent effects; ALT; alanine transaminase; CI; confidence interval; CRP; C-reactive protein; DMARDs; disease-modifying anti-rheumatoid drugs; DMS; duration of morning stiffness; ESR; erythrocyte sedimentation ra
Keywords: Ankylosing spondylitis; HLA B27; BASDAI; BASFI; Biologics; DMARDs;
Keywords: RA; rheumatoid arthritis; OA; osteoarthritis; U.S.; United States; OR; odds ratio; DM; diabetes mellitus; DMARDs; disease-modifying anti-rheumatic drugs; TNFα; tumor necrosis factor alpha; CPT; current procedural terminology; ICD-9; International Statist
Keywords: PPV23; pneumococcal polysaccharide vaccine; PCV7; pneumococcal conjugate vaccine; IPD; invasive pneumococcal disease; ANCA; antineutrophil cytoplasmic antibody; PR3-ANCA; ANCA directed against proteinase 3; MPO-ANCA; ANCA directed against myeloperoxidase;
Keywords: uveitis; pediatric; epidemiology; steroid sparing; biologic agents; AZA; Azathioprine; CS; Corticosteroids; DMARDs; Disease-modifying antirheumatic drugs; JIA; Juvenile idiopathic arthritis; MTX; Methotrexate; SUN; Standardization of Uveitis Nomenclature;
Keywords: ACR; American College of Rheumatology; bDMARDs; biologic disease-modifying antirheumatic drugs; DMARDs; disease-modifying antirheumatic drugs; EULAR; European League Against Rheumatism; GRAPPA; Group for Research and Assessment of Psoriasis and Psoriatic
Keywords: anti-CCP; anti-cyclic citrullinated peptide antibody; BMI; body mass index; CCL20; CC chemokine ligand 20; C/EBPβ; CCAAT-enhancer-binding protein β; CRP; C-reactive protein; CSF1R; colony stimulating factor 1 receptor; DAS28; disease activity score 28;
Keywords: Cytokines; Signal transduction; Drug development; Inflammation; Autoimmunity; Therapy; JAK; Janus Kinase; STAT; Signal transducer and activator of transcription; NF-kB; nuclear factor kappa-light-chain-enhancer of activated B cells; MAPK; Mitogen activate
Keywords: Rheumatologic diseases; Postpartum flare; DMARDs; Biologics; Lactation;
Keywords: End-stage renal disease; Rheumatoid arthritis; DMARDs; Biologics; Prednisone;
Keywords: Psoriatic arthritis; Biologic agents; DMARDs; Systematic review; Meta-analysis;
Keywords: Anti-TNF drugs; Rheumatoid arthritis; DMARDs; Biologicals;
Keywords: RA; rheumatoid arthritis; DCs; dendritic cells; TolDCs; tolerogenic dendritic cells; NSAIDs; non-steroidal anti-inflammatory drugs; GC; glucocorticoids; DMARDs; disease-modifying anti-rheumatic drugs; TLRs; toll-like receptors; CLRs; cell surface C-type l
Keywords: Rheumatoid arthritis; Treatment; Pathophysiology; DMARDs; Biologic agents
Keywords: Rheumatoid arthritis; Cancer; DMARDs; Epidemiology; Methotrexate;
Therapeutic effects of Smilax glabra and Bolbostemma paniculatum on rheumatoid arthritis using a rat paw edema model
Keywords: TFL; Smilax glabra Roxb. liliaceae; TBM; Bolbostemma paniculatum Maxim. Franquet (Cucurbitaceae); RA; rheumatoid arthritis; BFCM; n-butyl alcohol fraction of the couplet medicine; NSAIDs; non-steroidal anti-inflammatory drugs; DMARDs; disease-modifying an
Comorbidity of Type 1 Diabetes Mellitus in Patients with Juvenile Idiopathic Arthritis
Keywords: JIA; type 1 diabetes mellitus prevalence; autoimmune diseases; DMARDs; observational study; AID; Autoimmune disease; AIT; Autoimmune thyroiditis; bDMARD; Biological DMARD; BMI; Body mass index; CD; Celiac disease; cJADAS; Clinical Juvenile Arthritis Disea
Reprint of “Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab”
Keywords: AS; ankylosing spondylitis; ATA; anti-therapeutic antibodies; BASDAI; Bath Ankylosing Spondylitis Disease Activity Index; DAS28; Disease Activity Score 28; DMARDs; disease-modifying antirheumatic drugs; ECL; electrochemiluminescence; LoD; limit of detecti
The effects of DMARDs on the expression and function of P-gp, MRPs, BCRP in the treatment of autoimmune diseases
Keywords: DMARDs; Autoimmune diseases; Multidrug resistance; ABC transporters; P-glycoprotein;
Docosahexaenoic acid in the treatment of rheumatoid arthritis: AÂ double-blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil
Keywords: Rheumatoid arthritis; Docosahexaenoic acid; Docosanoids; Nutrition; Inflammation; Diseases activity; AA; arachidonic acid; ALA; α-linolenic acid; COX; cyclooxygenase; CRP; c-reactive protein; DAS28; disease activity score; DGLA; dihomo-γ-linolenic acid;
Nigella sativa fixed oil as alternative treatment in management of pain in arthritis rheumatoid
Keywords: Nigella sativa; Fixed oil; Thymoquinone; Arthritis rheumatoid; Pain; Inflammation; NSAIDs; Nonsteroidal anti-inflammatory drugs; DMARDs; non-biologic and biologic disease-modifying antirheumatic drugs; PMNL; polymorphonuclear leukocytes; SOD; Super oxide
The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritis
Keywords: ACPA; anti-citrullinated protein antibodies; ACR; American College of Rheumatology; AUC; area under the curve; BMI; body mass index; CDAI; Clinical Disease Activity Index; CI; confidence interval; CRP; C-reactive protein; DAS28; disease activity score-28
Repetitive 18F-FDG-PET/CT in patients with large-vessel giant-cell arteritis and controlled disease
Keywords: CRP; C-reactive protein; DMARDs; disease-modifying antirheumatic drugs; FDG-PET/CT; positron emission tomography with 18F-fluorodeoxyglucose (FDG) combined with computed tomography (PET/CT); GC; glucocorticoids; GCA; giant-cell arteritis; TAB; temporal ar
DMARD use is associated with a higher risk of dementia in patients with rheumatoid arthritis: A propensity score-matched case-control study
Keywords: Rheumatoid arthritis; Dementia; Conventional synthetic disease-modifying antirheumatic drugs; Biological disease-modifying antirheumatic drugs; RA; rheumatoid arthritis; DMARDs; disease-modifying antirheumatic drugs; csDMARDs; conventional synthetic DMARD
Clinical and sonographic biomarkers of structural damage progression in RA patients in clinical remission: A prospective study with 12 months follow-up
Keywords: ACPA; anti-citrullinated peptide/protein antibodies; BMI; body mass index; CCP2-ELISA; anti-cyclic citrullinated peptide-enzyme-linked immunosorbent assay; CI; confidence intervals; CRP; C-reactive protein; DAS28; 28-joint disease activity score; DMARDs;
Psychosocial predictors of DMARD adherence in the first three months of treatment for early arthritis
Keywords: Adherence; DMARDs; Early arthritis; Psychosocial factors;
Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)
Keywords: AE; adverse event; AOSD; adult-onset Still's disease; CI; confidence interval; DMARDs; disease modifying antirheumatic drug; IL-1 or 1β; interleukin-1 or 1β; MAS; macrophage activation syndrome; NSAIDs; non-steroidal anti-inflammatory drugs; SAE; seri
Research paperIn vitro allogeneic immune cell response to mesenchymal stromal cells derived from human adipose in patients with rheumatoid arthritis
Keywords: DMARDs; disease-modifying anti-rheumatic drugs; NSAIDs; nonsteroidal anti-inflammatory drugs; RA; rheumatoid arthritis; CIA; collagen-induced arthritis; MSCs; human adipose-derived stem cells; ACPA; anti-citrullinated protein antibody; Rheumatoid arthriti
Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab
Keywords: AS; ankylosing spondylitis; ATA; anti-therapeutic antibodies; BASDAI; Bath Ankylosing Spondylitis Disease Activity Index; DAS28; Disease Activity Score 28; DMARDs; disease-modifying antirheumatic drugs; ECL; electrochemiluminescence; LoD; limit of detecti
In vivo anti-arthritic efficacy of Camellia sinensis (L.) in collagen induced arthritis model
Keywords: RA; rheumatoid arthritis; IL; interleukins; Cox; cyclooxygenase; TNF α; tumour necrosis factor alpha; NSAID; nonsteroidal anti-inflammatory drugs; DMARDs; disease modifying anti-rheumatic drugs; Cs; Camellia sinensis (L.); LC-MS; liquid chromatographyâ
Therapeutic effect of Cryptotanshinone on experimental rheumatoid arthritis through downregulating p300 mediated-STAT3 acetylation
Keywords: RA; rheumatoid arthritis; CTS; Cryptotanshinone; DMARDs; disease-modifying anti-rheumatic drugs; FLS; fibroblast-like synoviocytes; CIA; type-II collagen-induced arthritis; STAT; Signal transducer and activator of transcription; IGU; iguratimod; Treg; reg
Pharmacotherapy Pearls for the Geriatrician
Keywords: Geriatrics; DMARDs; Rheumatology; Tofacitinib;
Effects of DMARDs on citrullinated peptide autoantibody levels in RA patients-A longitudinal analysis
Keywords: Rheumatoid arthritis; DMARDs; Anti-CCP2 antibodies; Immunglobulins;
Iridoid glycosides from the flowers of Gentiana macrophylla Pall. ameliorate collagen-induced arthritis in rats
Keywords: RA; rheumatoid arthritis; DMARDs; disease-modifying anti-rheumatic drugs; NSAIDs; non-steroidal anti-inflammatory drugs; GMI; iridoid glycosides from Gentiana macrophylla Pall.; COX-2; cyclooxygenase-2; iNOS; inducible nitric oxide; IL-1β; interleukin-1Î
Adult-onset Still's disease: Advances in the treatment
Keywords: Adult-onset Still's disease; DMARDs; Biologic agents; IL-1 receptor antagonist-anakinra; TNF-α inhibitors; Anti-IL-6 receptor antibody-tocilizumab; Macrophage activation syndrome;
New Treatment Guidelines for Sjögren's Disease
Keywords: Sjögren's; Treatment; Caries; Fatigue; Dry eye; Arthritis; DMARDS; Biologics;
Relation among anti-rheumatic drug therapy, CD14+CD16+ blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study
Keywords: Rheumatoid arthritis; DMARDs; Biological drugs; DAS28 score; US7 score; CD14+CD16+ monocytes;
The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy
Keywords: IL-17; IL-22; Th17 cells; Rheumatoid Arthritis; Immunotherapy; AIA; antigen-induced arthritis; CCR; c-c chemokine receptor; CIA; collagen-induced arthritis; CRP; C-reactive protein; CTLA-8; cytotoxic T lymphocyte associated antigen 8; DMARDs; disease modi
Interaction between TGF-β1 (869C/T) polymorphism and biochemical risk factor for prediction of disease progression in rheumatoid arthritis
Keywords: BMD; bone mineral density; CRP; C-reactive protein; DMARDs; disease-modifying antirheumatic drugs; DEXA study; dual-energy X-ray absorptiometry; ESR; erythrocyte sedimentation rate; HAQ; Health Assessment Questionnaire; PCR-RFLP; polymerase chain reaction
Association of HLA-E*01:01/*01:03 polymorphism with methotrexate-based treatment response in South Indian rheumatoid arthritis patients
Keywords: DMARDs; HLA-E polymorphism; Immunogenetics; Rheumatoid arthritis; Treatment response
Unmet needs in the treatment of autoimmunity: From aspirin to stem cells
Keywords: Rheumatoid arthritis; Systemic lupus erythematosus; DMARDS; Glucocorticoids; Biological response modifiers; Janus associated kinase inhibitors;
The extrapituitary prolactin promoter polymorphism is associated with rheumatoid arthritis and anti-CCP antibodies in Mexican population
Keywords: PRL; prolactin; RA; rheumatoid arthritis; anti-CCP; anti-cyclic citrullinated peptide; SNP; single nucleotide polymorphism; CS; control subjects; RF; rheumatoid factor; hsCRP; high sensibility C reactive protein; ESR; erythrocyte sedimentation rate; HPRL;